HealthGenmab Reports Tumor Responses With Experimental Colorectal Cancer CombinationBy Naomi CalderOct 25, 2026, 11:21 AM UTC
HealthKelun-Biotech Reports Longer Progression-Free Survival in Phase 3 Lung TrialBy Naomi CalderOct 25, 2026, 10:50 AM UTC
HealthGenmab and Incyte Plan Phase 1/2 Trial for KRAS G12D Colorectal CancerBy Naomi CalderOct 24, 2026, 2:02 PM UTC
HealthZanidatamab Regimen Shows 39.8% Estimated Three-Year SurvivalBy Naomi CalderOct 24, 2026, 1:20 AM UTC
InvestingModerna Shares Fall 17.57% After Melanoma Trial Results Surface EarlyBy Celia RowanOct 23, 2026, 8:19 PM UTC
Healthargenx Eyes Up to Five Potential U.S. Launches for 2027By Naomi CalderOct 23, 2026, 7:24 PM UTC
HealthTezspire Shows Higher Eosinophilic Esophagitis Remission Rates Through Week 52By Naomi CalderOct 21, 2026, 10:47 AM UTC
HealthAstraZeneca and Oracle Plan AI Trial Recruitment Program in Abu DhabiBy Naomi CalderOct 20, 2026, 2:42 PM UTC
